Literature DB >> 30894745

Novel tau filament fold in chronic traumatic encephalopathy encloses hydrophobic molecules.

Michel Goedert1, Sjors H W Scheres2, Benjamin Falcon3, Jasenko Zivanov3, Wenjuan Zhang3, Alexey G Murzin3, Holly J Garringer4, Ruben Vidal4, R Anthony Crowther3, Kathy L Newell5, Bernardino Ghetti4.   

Abstract

Chronic traumatic encephalopathy (CTE) is a neurodegenerative tauopathy that is associated with repetitive head impacts or exposure to blast waves. First described as punch-drunk syndrome and dementia pugilistica in retired boxers1-3, CTE has since been identified in former participants of other contact sports, ex-military personnel and after physical abuse4-7. No disease-modifying therapies currently exist, and diagnosis requires an autopsy. CTE is defined by an abundance of hyperphosphorylated tau protein in neurons, astrocytes and cell processes around blood vessels8,9. This, together with the accumulation of tau inclusions in cortical layers II and III, distinguishes CTE from Alzheimer's disease and other tauopathies10,11. However, the morphologies of tau filaments in CTE and the mechanisms by which brain trauma can lead to their formation are unknown. Here we determine the structures of tau filaments from the brains of three individuals with CTE at resolutions down to 2.3 Å, using cryo-electron microscopy. We show that filament structures are identical in the three cases but are distinct from those of Alzheimer's and Pick's diseases, and from those formed in vitro12-15. Similar to Alzheimer's disease12,14,16-18, all six brain tau isoforms assemble into filaments in CTE, and residues K274-R379 of three-repeat tau and S305-R379 of four-repeat tau form the ordered core of two identical C-shaped protofilaments. However, a different conformation of the β-helix region creates a hydrophobic cavity that is absent in tau filaments from the brains of patients with Alzheimer's disease. This cavity encloses an additional density that is not connected to tau, which suggests that the incorporation of cofactors may have a role in tau aggregation in CTE. Moreover, filaments in CTE have distinct protofilament interfaces to those of Alzheimer's disease. Our structures provide a unifying neuropathological criterion for CTE, and support the hypothesis that the formation and propagation of distinct conformers of assembled tau underlie different neurodegenerative diseases.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30894745      PMCID: PMC6472968          DOI: 10.1038/s41586-019-1026-5

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  3 in total

1.  Free fatty acids stimulate the polymerization of tau and amyloid beta peptides. In vitro evidence for a common effector of pathogenesis in Alzheimer's disease.

Authors:  D M Wilson; L I Binder
Journal:  Am J Pathol       Date:  1997-06       Impact factor: 4.307

2.  Silver staining of Alzheimer's neurofibrillary changes by means of physical development.

Authors:  F Gallyas
Journal:  Acta Morphol Acad Sci Hung       Date:  1971

3.  Tau isoform profile and phosphorylation state in dementia pugilistica recapitulate Alzheimer's disease.

Authors:  M L Schmidt; V Zhukareva; K L Newell; V M Lee; J Q Trojanowski
Journal:  Acta Neuropathol       Date:  2001-05       Impact factor: 17.088

  3 in total
  202 in total

1.  Native nanodiscs formed by styrene maleic acid copolymer derivatives help recover infectious prion multimers bound to brain-derived lipids.

Authors:  Mansoore Esmaili; Brian P Tancowny; Xiongyao Wang; Audric Moses; Leonardo M Cortez; Valerie L Sim; Holger Wille; Michael Overduin
Journal:  J Biol Chem       Date:  2020-05-01       Impact factor: 5.157

2.  4-Repeat tau seeds and templating subtypes as brain and CSF biomarkers of frontotemporal lobar degeneration.

Authors:  Eri Saijo; Michael A Metrick; Shunsuke Koga; Piero Parchi; Irene Litvan; Salvatore Spina; Adam Boxer; Julio C Rojas; Douglas Galasko; Allison Kraus; Marcello Rossi; Kathy Newell; Gianluigi Zanusso; Lea T Grinberg; William W Seeley; Bernardino Ghetti; Dennis W Dickson; Byron Caughey
Journal:  Acta Neuropathol       Date:  2019-10-16       Impact factor: 17.088

3.  N-Terminal Acetylation Affects α-Synuclein Fibril Polymorphism.

Authors:  Matthew D Watson; Jennifer C Lee
Journal:  Biochemistry       Date:  2019-08-21       Impact factor: 3.162

4.  In vitro 0N4R tau fibrils contain a monomorphic β-sheet core enclosed by dynamically heterogeneous fuzzy coat segments.

Authors:  Aurelio J Dregni; Venkata S Mandala; Haifan Wu; Matthew R Elkins; Harrison K Wang; Ivan Hung; William F DeGrado; Mei Hong
Journal:  Proc Natl Acad Sci U S A       Date:  2019-07-29       Impact factor: 11.205

5.  Structural and molecular basis of cross-seeding barriers in amyloids.

Authors:  Asen Daskalov; Denis Martinez; Virginie Coustou; Nadia El Mammeri; Mélanie Berbon; Loren B Andreas; Benjamin Bardiaux; Jan Stanek; Abdelmajid Noubhani; Brice Kauffmann; Joseph S Wall; Guido Pintacuda; Sven J Saupe; Birgit Habenstein; Antoine Loquet
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-05       Impact factor: 11.205

6.  Crystal structure of a conformational antibody that binds tau oligomers and inhibits pathological seeding by extracts from donors with Alzheimer's disease.

Authors:  Romany Abskharon; Paul M Seidler; Michael R Sawaya; Duilio Cascio; Tianxiao P Yang; Stephan Philipp; Christopher Kazu Williams; Kathy L Newell; Bernardino Ghetti; Michael A DeTure; Dennis W Dickson; Harry V Vinters; Philip L Felgner; Rie Nakajima; Charles G Glabe; David S Eisenberg
Journal:  J Biol Chem       Date:  2020-06-03       Impact factor: 5.157

7.  Structure-based inhibitors halt prion-like seeding by Alzheimer's disease-and tauopathy-derived brain tissue samples.

Authors:  Paul Matthew Seidler; David R Boyer; Kevin A Murray; Tianxiao P Yang; Megan Bentzel; Michael R Sawaya; Gregory Rosenberg; Duilio Cascio; Christopher Kazu Williams; Kathy L Newell; Bernardino Ghetti; Michael A DeTure; Dennis W Dickson; Harry V Vinters; David S Eisenberg
Journal:  J Biol Chem       Date:  2019-09-19       Impact factor: 5.157

8.  Structural Insights into α-Synuclein Fibril Polymorphism: Effects of Parkinson's Disease-Related C-Terminal Truncations.

Authors:  Xiaodan Ni; Ryan P McGlinchey; Jiansen Jiang; Jennifer C Lee
Journal:  J Mol Biol       Date:  2019-07-08       Impact factor: 5.469

9.  Parkinson's disease-related phosphorylation at Tyr39 rearranges α-synuclein amyloid fibril structure revealed by cryo-EM.

Authors:  Kun Zhao; Yeh-Jun Lim; Zhenying Liu; Houfang Long; Yunpeng Sun; Jin-Jian Hu; Chunyu Zhao; Youqi Tao; Xing Zhang; Dan Li; Yan-Mei Li; Cong Liu
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-31       Impact factor: 11.205

10.  Insoluble Tau From Human FTDP-17 Cases Exhibit Unique Transmission Properties In Vivo.

Authors:  Sarah A Weitzman; Sneha Narasimhan; Zhuohao He; Lakshmi Changolkar; Jennifer D McBride; Bin Zhang; Gerard D Schellenberg; John Q Trojanowski; Virginia M Y Lee
Journal:  J Neuropathol Exp Neurol       Date:  2020-09-01       Impact factor: 3.685

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.